| Filed | Form | Description | |
|---|---|---|---|
| 11/10/25 | DEFA14A | DEFA14A | → |
| 11/10/25 | DEF 14A | DEF 14A | → |
| 10/29/24 | DEFA14A | DEFA14A | → |
| 10/29/24 | DEF 14A | DEF 14A | → |
| 10/26/23 | DEFA14A | DEFA14A | → |
| 10/26/23 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/2/26 | 3 | 3 | → |
| 1/13/26 | 4 | 4 | → |
| 1/13/26 | 3 | 3 | → |
| 1/13/26 | 4 | 4 | → |
| 1/13/26 | 3 | 3 | → |
| 1/12/26 | 4 | 4 | → |
| ↓ | |||
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.